Table 1. Baseline characteristics of the subjects.
| Weight reduction (N = 9) | Control (N = 10) | p-value* | |
| Gender (males/females) | 4/5 | 4/6 | |
| Age (y) | 58±7 | 62±8 | NS |
| Weight (kg) | 97.8±19.8 | 86.6±6.6 | NS |
| BMI (kg/m2) | 34.2±4.3 | 31.8±2.6 | NS |
| Blood pressure (mmHg) | |||
| Systolic | 140±14 | 135±9 | NS |
| Diastolic | 95±7 | 84±7 | 0.001 |
| Waist circumference (cm) | 111±12 | 104±7 | NS |
| Body fat (%) | 39.7±6.8 | 38.8±7.4 | NS |
| Serum cholesterol (mmol/l) | |||
| Total | 5.4±1.1 | 4.9±0.7 | NS |
| HDL | 1.12±0.17 | 1.29±0.17 | NS |
| LDL | 3.61±0.91 | 3.10±0.52 | NS |
| VLDL | 0.69±0.36 | 0.51±0.27 | NS |
| Serum triglycerides (mmol/l) | 1.81±0.84 | 1.61±0.57 | NS |
| SI; insulin sensitivity index (mU/l)−1min−1 | 1.78+0.42 | 2.66+0.97 | 0.027 |
*
Mann-Whitney's U-test for independent samples.